Our Leadership
Discover why Peapod Bio is the leader in innovative and accelerated assay solutions
Founded in 2025, Peapod Bio is rapidly becoming the industry leader in assay development and high-throughput screening with an elite team of experts dedicated to delivering high-quality results faster than any other CRO. Peapod Bio’s mission is to reliably work with you as an extension of your own lab to ensure you achieve your drug discovery goals and build confidence in your results. Whether benefiting from our label-free or beyond label-free assay solutions, Peapod Bio’s flexible approach is guided by rigorous scientific standards and clear, consistent communication, ensuring full transparency with no surprises in your data, timelines, or costs.
Peapod Bio supports small molecule discovery research across a variety of therapeutic areas. We help you investigate early-stage modulators of enzymes, identify small molecule binders to virtually any target, and drive the discovery of molecular glues and other proximity inducing small molecules. If you need rapid turnaround and high-quality results to make go or no-go decisions, Peapod Bio’s value-driven solutions and team deliver results.
-
Zachary Gurard-Levin, PhD
Chief Executive Officer & Founder
-
Flora Kimani, PhD
Operations Director
-
Patrick O’Kane, PhD
Technology Director

Contact our assay experts